Researchers create model of anorexia nervosa using stem cellsMedical XpressAn international research team, led by scientists at University of California San Diego School of Medicine, has created the first cellular model of anorexia nervosa (AN), reprog… Continue reading
DIGITALLOOKMaxCyte signs cell platform deal with CRISPR and CasebiaDIGITALLOOKCRISPR Therapeutics, a Nasdaq-listed biopharmaceutical company focussed on creating transformative gene-based medicines for serious diseases, and Casebia Therapeutics, a join… Continue reading
Proactive Investors UK |
CRISPR Therapeutics Licenses Cell Engineering Platform From MaxCyte
GenomeWeb NEW YORK (GenomeWeb) – CRISPR Therapeutics and Casebia Therapeutics, its joint venture with Bayer, have signed a licensing deal for a cell transfection platform from MaxCyte. Under the terms of the agreement, CRISPR Therapeutics and Casebia will … CRISPR Therapeutics and Casebia Therapeutics Announce …Yahoo Finance CRISPR Therapeutics and JV with Bayer nab non-exclusive rights to MaxCyte’s cell engineering platformSeeking Alpha MaxCyte Inks License Deal With CRISPR Therapeutics And Bayer …London South East (registration) (blog) Proactive Investors UK all 7 news articles » |
NutraIngredients-usa.com |
Peptide aimed at stem cell genesis debuts on supplement market
NutraIngredients-usa.com The peptide in DH Stemogen targets a particular type of stem cell – hematopoietic cells (HSC). Stem cells in general are the building blocks of our bodies. These cells are able to transform themselves into almost any type of cell. There are various … |